Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 7Recruiting 5Unknown 2Active not recruiting 2Withdrawn 1Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 1

Conditions

Pancreatic Neoplasms 4Peritoneal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Locally Advanced Pancreatic Cancer 1Gastroparesis 1

Interventions

Oxaliplatin 197Bevacizumab 161Fluorouracil 154Capecitabine 137Gemcitabine 134Leucovorin 111pembrolizumab 99Cisplatin 94Drug Therapy 89Irinotecan 80Radiotherapy 73sintilimab 70130-nm albumin-bound paclitaxel 66durvalumab 65Paclitaxel 64Specimen Handling 62Cetuximab 61lenvatinib 59tislelizumab 58Nivolumab 55Magnetic Resonance Spectroscopy 55Folfox protocol 55Blood Specimen Collection 52atezolizumab 47Biopsy 46Surgical Procedures, Operative 40Taxes 39Albumin-Bound Paclitaxel 39Immune Checkpoint Inhibitors 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Pancreatectomy × Gastrointestinal × Clear all
NCT07493421 2026-03-25

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

Unidade Local de Saúde São João

Phase NA Recruiting
20 enrolled
GastrointestinalGynecologic

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms

NCT07396662 2026-02-09

Endocrine-exocrine Functions and Prognosis After Pancreatectomy

National Taiwan University Hospital

Recruiting
3,500 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07382791 2026-02-03

Delayed Gastric Emptying After Pancreatic Surgery

National Taiwan University Hospital

Recruiting
3,500 enrolled
Gastrointestinal

Pancreatic Neoplasms, Gastroparesis

NCT06944587 2025-04-25

NORPACT-3

Oslo University Hospital

Recruiting
400 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡